GEORGE R BLUMENSCHEIN to Quality of Life
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Quality of Life.
Connection Strength
0.070
-
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1104-1115.
Score: 0.053
-
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med. 2016 11 10; 375(19):1856-1867.
Score: 0.013
-
Treatment for meningeal carcinomatosis in breast cancer. Cancer. 1982 Jul 15; 50(2):219-22.
Score: 0.005